Effects of combining durvalumab with chemotherapy in individuals suffering from advanced biliary tract cancer: an investigation into the prognostic nutritional index, systemic immune-inflammation index and patient survival outcomes.
OBJECTIVE To evaluate the dynamic effects of durvalumab plus chemotherapy on the prognostic nutritional index (PNI) and systemic immune-inflammation index (SII) in patients with advanced biliary tract cancer (BTC), and to develop a nomogram for individualized prognostic assessment. METHODS Clinical data from 417 pati...